Vor Biopharma Inc. (VOR) Earnings History
Net Loss8 years of earnings data (2018–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Vor Biopharma Inc. (VOR) Earnings Overview
As of July 7, 2026, Vor Biopharma Inc. (VOR) reported trailing twelve-month net income of -$883M, reflecting -107.4% year-over-year growth. The company earned $-2053.13 per diluted share over the past four quarters.
Looking at the long-term picture, VOR's historical earnings data spans multiple years. The company achieved its highest annual net income of -$4M in fiscal 2018.
Vor Biopharma Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including BEAM (-$65M net income, -57.2% margin), CRSP (-$569M net income, -16569.8% margin), EDIT (-$109M net income, -395.0% margin), VOR has comparable earnings metrics. Compare VOR vs BEAM →
VOR Earnings vs Peers
Earnings metrics vs comparable public companies
VOR Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$696M | -495.3% | -$372M | $-70.50 | - | - |
| 2024 | -$117M | +0.8% | -$121M | $-34.00 | - | - |
| 2023 | -$118M | -28.0% | -$126M | $-35.00 | - | - |
| 2022 | -$92M | -33.7% | -$93M | $-46.60 | - | - |
| 2021 | -$69M | -59.0% | -$69M | $-37.80 | - | - |
| 2020 | -$43M | -299.8% | -$43M | $-26.60 | - | - |
| 2019 | -$11M | -161.1% | -$10M | $-6.20 | - | - |
| 2018 | -$4M | - | -$3M | $-14.60 | - | - |
Download Data
Export VOR earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
VOR — Frequently Asked Questions
Quick answers to the most common questions about buying VOR stock.
What is VOR earnings per share (EPS)?
VOR trailing twelve-month (TTM) diluted EPS is $-2053.13, reflecting -107.4% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is Vor Biopharma Inc.'s net income?
Vor Biopharma Inc. (VOR) trailing twelve-month net income is $-883M as of 2025. Earnings declined -107.4% year-over-year.
Is VOR profitable?
VOR is not currently profitable on a TTM basis, reporting a net loss of $-883M. Net margin is N/A. Investors should monitor for a return to profitability.
What is VOR's earnings growth rate?
VOR compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are VOR's profit margins?
Vor Biopharma Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.
Is VOR growing earnings?
VOR earnings are declining — EPS fell -107.4% year-over-year. TTM net income dropped to $-883M. This contrasts with the 5-year CAGR of N/A.
What was VOR's best earnings year?
Vor Biopharma Inc.'s highest annual net income on record is $-4M, achieved in fiscal year 2018. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were VOR's earnings last quarter?
VOR's most recent reported quarter was Q1 2026. Net income was $-220M with diluted EPS of $-510.53. For a full breakdown of all quarters, see the quarterly earnings table on this page.